GHB and GBL Addiction Treatment
GHB and GBL Addiction Treatment
Confidential residential treatment for GHB and GBL addiction provided under round-the-clock medical supervision. Treatment focuses on safe stabilisation, prevention of severe withdrawal complications and intensive psychiatric and therapeutic care.
As part of our clinical approach to depressant and dissociative substance addiction treatment, we offer an individualised inpatient programme for patients with GHB or GBL dependency. All clinical contact is confidential and non-binding.
What are GHB and GBL
GHB (gamma-hydroxybutyric acid) and GBL (gamma-butyrolactone) are psychoactive substances with a depressant effect on the central nervous system. Although they are chemically distinct, GBL is rapidly converted to GHB in the body, which is why they are treated as the same substance in clinical practice.
These substances are sometimes used recreationally for their effects of relaxation and euphoria, reduction of social anxiety, increased libido and facilitation of sleep. At the same time, they are among the most dangerous substances in terms of addiction risk and sudden death.
GHB and GBL addiction as a high-risk condition
GHB and GBL addiction develops very rapidly, often within weeks or months. A characteristic feature is the need to take the substance every few hours, including during the night, in order to avoid severe withdrawal symptoms. The disorder is characterised by strong physical and psychological dependence, a narrow margin between an effective and a toxic dose, a high risk of overdose, and a potentially fatal withdrawal syndrome.
When urgent medical attention is required
Urgent medical attention is required if any of the following occur during withdrawal: seizures, loss of consciousness, severe disorientation, symptoms of psychosis, aggressive behaviour disproportionate to the situation, severe chest pain, shortness of breath or suspected overdose. In these situations, no attempt should be made to manage the condition independently. Patient safety and rapid clinical assessment are always the priority. In any life-threatening or health-threatening situation, emergency services should be contacted immediately by calling 112.
How GHB and GBL affect the brain
GHB acts primarily on GABA receptors, GHB receptors and the dopaminergic system. The result is strong inhibition of the central nervous system, impairment of consciousness, sedation, memory disturbances including amnesia, and loss of control over dosing. Long-term use leads to profound neurochemical dysregulation, which is what makes sudden cessation exceptionally dangerous.
Symptoms of GHB and GBL addiction
Psychological symptoms
- severe anxiety and panic between doses
- disorientation
- mood instability
- insomnia
- paranoid episodes
- hallucinations during withdrawal
Physical symptoms
- muscle tremors
- tachycardia
- elevated blood pressure
- sweating
- nausea and vomiting
- seizures upon withdrawal
Behavioural symptoms
- taking the substance every two to four hours
- waking during the night to take a dose
- inability to function without GHB or GBL
- concealing use from those around them
- polysubstance use including alcohol, stimulants and benzodiazepines
Why GHB and GBL withdrawal is exceptionally dangerous
GHB and GBL withdrawal syndrome can be comparable to or more severe than withdrawal from alcohol or benzodiazepines. It can lead to severe delirium, seizures, cardiac arrhythmia, acute psychosis, cardiorespiratory failure and death.
Self-managed cessation of GHB or GBL is contraindicated and potentially fatal.
GHB and GBL addiction treatment at Zeus Detox & Rehab
Treatment is provided exclusively in residential conditions, within a structured drug addiction treatment programme, with full medical and psychiatric support. The priority of the therapeutic process is patient safety, continuous clinical supervision and management of the rapid and potentially life-threatening withdrawal syndrome characteristic of GHB and GBL.
Stages of GHB and GBL addiction treatment
Treatment of GHB and GBL addiction at Zeus Detox & Rehab generally proceeds through four main clinical stages.
Stage 1 - Clinical qualification and assessment
The treatment process begins with an urgent medical consultation including assessment of the pattern of substance use, dosing and frequency, laboratory testing, evaluation of seizure and delirium risk, and diagnosis of co-occurring psychiatric disorders.
Stage 2 - Medically supervised detoxification
GHB and GBL detox includes gradual neurochemical stabilisation, pharmacological prevention of seizures and delirium, round-the-clock monitoring of vital signs, treatment of anxiety, insomnia and agitation, and continuous nursing care. This is the most critical stage of treatment.
Stage 3 - Psychiatric treatment and therapy
Once stabilisation has been achieved, individual psychotherapy is introduced. This phase includes treatment of anxiety and depressive disorders, work on the mechanisms of compulsive use, relapse prevention therapy and management of polysubstance dependency where present.
Stage 4 - Planning of further care
The process includes preparation of a post-discharge treatment plan, recommendations for outpatient or further residential therapy, continuation of psychiatric support and development of a long-term patient safety strategy.
Important clinical information
GHB and GBL detoxification is one of the highest-risk procedures in addiction medicine. In cases of severe withdrawal syndrome, treatment in an intensive care unit may be the only safe course of action. The patient and their family are informed of this risk during the clinical qualification process. In the event of delirium, acute psychosis, seizures or failure to respond to intensive pharmacological treatment, the patient may be transferred to hospital care including an intensive care unit.
Limitations of residential treatment and situations requiring acute hospitalisation
GHB and GBL detoxification at Zeus Detox & Rehab is conducted in residential conditions under round-the-clock medical supervision, in accordance with current safety standards. In certain clinical situations, treatment in a detoxification unit may prove insufficient or inappropriate. This applies in particular where the patient develops acute withdrawal psychosis, severe psychomotor agitation, pronounced delirium, or life-threatening disturbances of consciousness that do not resolve despite high doses of sedative and anticonvulsant medication administered at the physician's discretion.
In such situations, guided by the overriding principle of patient safety, a decision may be made for the urgent transfer of the patient to a hospital with an intensive care unit, the capacity for continuous monitoring of vital functions, and the ability to initiate controlled intravenous sedation using infusion pumps. The decision to transfer a patient to acute hospital care is made exclusively on the basis of the patient's current clinical condition and does not constitute a refusal of treatment, but is part of responsible medical practice.
When inpatient treatment for GHB and GBL addiction is indicated
For whom residential treatment may be appropriate
- individuals taking GHB or GBL daily or multiple times per day
- withdrawal symptoms between doses
- episodes of loss of consciousness or overdose
- co-occurring psychiatric disorders
- polysubstance addiction
- unsuccessful attempts at self-managed cessation
When another level of care is required
- acute life-threatening condition requiring emergency or intensive care
- lack of patient consent to inpatient treatment
- lack of readiness for residential treatment
Every decision is preceded by an individual clinical assessment.
Scope of treatment and clinical responsibility
Residential treatment focuses on medical stabilisation, evaluation of the patient's psychological state and intensive therapeutic work in the acute or advanced phase of the disorder. It does not replace long-term outpatient treatment and does not guarantee any specific clinical outcome. Planning of further care is an integral part of the therapeutic process.
FAQ
CLINICAL INQUIRY
The form is intended for submitting a clinical inquiry. Messages are delivered directly to the team responsible for treatment coordination.
Related Treatment Areas
Clinical Contact
Contact with the center is intended for providing information regarding inpatient treatment and coordinating next steps in a confidential and non-binding manner.
Scope of Treatment and Informational Nature of Content
Inpatient treatment provided at Zeus Detox & Rehab is clinical in nature and focuses on medical stabilization, psychiatric assessment, and therapeutic intervention appropriate to the diagnosed condition and stage of the disorder. The scope and structure of treatment are determined individually by the clinical team based on the patient’s current health status and applicable medical standards.
The information presented on this website is for educational and informational purposes only. It does not constitute medical advice and should not be used as a basis for self-directed treatment decisions. Addiction and mental health treatment require individual medical qualification and clinical assessment.